Albuterol /00139501/


Combined with:

Enbrel

Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 54.5%
Pain 12.1%
Drug Abuse 9.1%
Chronic Obstructive Pulmonary Disease 6.1%
Anxiety 3.0%
Arthralgia 3.0%
Insomnia 3.0%
Pain In Extremity 3.0%
Panic Attack 3.0%
Sleep Disorder 3.0%
Reaction To Drug Excipients 50.0%
Vomiting 50.0%
Concomitant
Product Used For Unknown Indication 75.7%
Asthma 4.4%
Hepatitis C 3.0%
Chronic Obstructive Pulmonary Disease 2.8%
Hypertension 1.6%
Rheumatoid Arthritis 1.5%
Pain 1.4%
Depression 1.1%
Osteoporosis 1.0%
Gastrooesophageal Reflux Disease 0.9%
Anxiety 0.8%
Psoriasis 0.7%
Prophylaxis 0.7%
Pulmonary Hypertension 0.7%
Cystic Fibrosis 0.6%
Diabetes Mellitus 0.6%
Hereditary Angioedema 0.6%
Ill-defined Disorder 0.6%
Back Pain 0.6%
Nausea 0.6%
Pneumonia 11.0%
Sinusitis 9.7%
Vomiting 7.1%
Death 6.5%
Drug Ineffective 6.5%
Weight Decreased 5.8%
Pain 5.2%
Pain In Extremity 5.2%
Injection Site Pain 4.5%
Rash 4.5%
Upper Respiratory Tract Infection 4.5%
Bronchitis 3.9%
Product Quality Issue 3.9%
Psoriasis 3.9%
Therapeutic Response Decreased 3.9%
Injection Site Swelling 3.2%
Visual Acuity Reduced 3.2%
Asthma 2.6%
Malignant Neoplasm Progression 2.6%
Paraesthesia 2.6%
Interacting
Product Used For Unknown Indication 84.2%
Metastases To Bone 5.3%
Prostate Cancer 5.3%
Prostate Cancer Metastatic 5.3%
Dyspnoea 100.0%

Drug Data